Markets Screener Institutions Status About FAQ Insights API

Loading institutional data...

Request data / API access →

Data from SEC EDGAR filings: company financials and 13F holdings.

Disclaimer: QW Research is provided for informational and educational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data is derived from public SEC 13F filings and may be incomplete, delayed, or inaccurate. Do not make investment decisions based on this content. QW Research does not share in any profits and accepts no liability for any losses or decisions made using this information. Past performance does not predict future results.

QW Research © 2026

NRSNW — Fundamentals, Valuation & Ownership | QW Research

Back to Markets

NeuroSense Therapeutics Ltd. (NRSNW)

Neutral

Institutional ownership roughly stable: +0.10% change quarter-over-quarter.

Data as of Q1 2026

Loading snapshot...

Loading financials...

Loading valuation...

Loading quality & risk...

Loading dividends & returns...

Loading capital allocation...

Loading debt & leverage...

Loading performance...

Loading peer comparison...

Loading ownership map...

Loading crowding analysis...

Loading conviction analysis...

Institutional Ownership

1.2%

of shares outstanding · 13 funds hold it

Ownership Change

0.10 pts

institutions added to their stake last quarter

Crowding

72ᵗʰ pctl

more crowded than 72% of tracked stocks

Institutional Value

$287K

total position value across all 13F filers

Loading buy/sell flow...

Loading ownership trends...

Loading top holders...

Institutional Holders

Loading top holders...

No collected fundamentals to build a valuation model.

No collected fundamentals for a quality & risk analysis.

No collected fundamentals for a dividends & returns analysis.

No collected fundamentals for a capital-allocation analysis.

Loading ownership map...

Loading crowding analysis...

Buy / Sell Volume by Quarter

Total shares institutions bought (green) vs sold (red) each quarter across all holders.

Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.

Institutional Trends (8 Quarters)

Conviction-Weighted Ownership

Median weight: 0.00%Avg weight: 0.01%Max: 0.04%High conviction (>1%): 0

Empery Asset Management,

Yorkville Advisors Global,

Clear Street Group

Independent Advisor Alliance

TWO SIGMA INVESTMENTS,

MEITAV INVESTMENT HOUSE

JANE STREET GROUP,

COMMONWEALTH EQUITY SERVICES,

PNC FINANCIAL SERVICES GROUP,

Crowding AnalysisModerate

Holders13of 5,944

Avg: 68

Uncrowded72th percentileCrowded

Institutional Activity

Buy/Sell Ratio0.67x

34th percentile

4 buying6 selling

+3

New

-3

Closed

+34K

Net shares

Ownership Concentration

Top 5: 90.1%Top 10: 131.4%

Empery Asset Management,26.4%

Yorkville Advisors Global,20.5%

Clear Street Group16.7%

UBS Group AG13.2%

Independent Advisor Alliance13.2%

Others (8)9.9%

Crowding AnalysisModerate

Holders13of 5,944

Avg: 68

Uncrowded72th percentileCrowded

Institutional Activity

Buy/Sell Ratio0.67x

34th percentile

4 buying6 selling

+3

New

-3

Closed

+34K

Net shares

Ownership Concentration

Top 5: 90.1%Top 10: 131.4%

Empery Asset Management,26.4%

Yorkville Advisors Global,20.5%

Clear Street Group16.7%

UBS Group AG13.2%

Independent Advisor Alliance13.2%

Others (8)9.9%

Performance vs. S&P 500

Total return (dividends reinvested) vs the market, from quarter-end prices.

$10,000 invested 2021-12

$2,276

NRSNW · -77%

$14,515

S&P 500 · +45%

−$12,239

behind the index

Total return (5Y)

-77%

S&P 500

+45%

vs. market

-122%

underperformed

Annualized

-29.4%

mkt 9.2%

Volatility

273%

annualized

Beta

6.67

vs S&P 500

Growth of $10,000

Hover the chart to read any quarter

NRSNWS&P 500

Year by year

Annual return vs the market

Hover a year to compare.

NRSNW (solid)S&P 500 (outline)Green = positive year, red = negative. Number = NRSNW's return.

Beat the market

1 / 5 yrs

20% win rate

Best year

+463%

2024

Worst year

-82%

2022

Worst drawdown

-91%

still -77% below peak

Relative strength

Cumulative lead over the S&P 500

Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.

Downside

Drawdown from peak · max -91%

How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.

Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.

No collected fundamentals for a debt & leverage analysis.

Ownership Map

Top 15 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.

Size by

Drag any bubble to rearrange · size = dollar value of the position

Ownership Map

Top 15 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.

Size by

Drag any bubble to rearrange · size = dollar value of the position

We haven't collected financials for NRSNW yet, so it can't be scored against its Healthcare peers.